≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Acute lymphocytic leukaemia, helper endpoint

Endpoint Browser

HLP_C3_ALL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 981[1-8]|9835
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

237

4. Check minimum number of events

None

237

5. Include endpoints

None

237

6. Filter based on genotype QC (FinnGen only)

237

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 237 132 105
Unadjusted period prevalence (%) 0.05 0.04 0.05
Median age at first event (years) 9.23 6.99 12.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
237
Matched controls
2368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8615.7
309.6
229
6
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
268.8
204
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
237.1
186
*
L01BB02
ATC
mercaptopurine; oral
495.0
167.1
149
8
H02AB02
ATC
dexamethasone; systemic
305.5
137.2
128
9
TAB00
NOMESCO Finland
Lumbar puncture
80.3
125.6
139
41
XW000
NOMESCO Finland
Bone marrow biopsy
116.4
101.2
105
16
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
136.2
100.1
102
13
H02AB09
ATC
hydrocortisone; systemic
66.1
97.5
111
31
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
81.0
73
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
23.0
68.8
105
79
L03AA02
ATC
filgrastim; parenteral
418.6
64.8
62
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
77.2
64.2
71
13
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
347.4
55.7
54
*
A04AA01
ATC
ondansetron; systemic, rectal
53.0
53.4
63
16
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
53.1
49
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
50.9
47
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
55.8
47.9
56
13
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
30.2
46.7
63
28
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
45.3
42
*
ZX131
NOMESCO Finland
Intrathecal
+∞
41.9
39
*
A41.9
ICD-10 Finland
Sepsis, unspecified
36.8
39.3
50
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.7
38.5
70
70
WW500
NOMESCO Finland
Blood transfusion
26.0
35.8
50
24
R50.9
ICD-10 Finland
Fever, unspecified
7.0
34.8
103
234
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
34.2
32
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
23.7
33.5
48
25
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
33.1
31
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
32.0
30
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
10.6
32.0
66
83
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
357.4
31.6
31
*
J05AB11
ATC
valaciclovir; oral
8.6
31.5
75
121
ZX114
NOMESCO Finland
Intramuscular
68.0
31.0
35
6
H02AB06
ATC
prednisolone; systemic
5.1
30.7
148
581
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
28.7
27
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
316.8
28.4
28
*
127
Kela drug reimbursment
Transplant complication
21.3
27.8
41
23
A05AA02
ATC
ursodeoxycholic acid; oral
29.0
27.6
37
15
1XX02
NOMESCO Finland
NA
+∞
26.6
25
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
26.6
25
*
J02AC01
ATC
fluconazole; systemic
4.5
25.3
128
493
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
24.4
23
*
9101
FHL
Bone biopsy
96.9
24.2
26
*
K03.66
ICD-10 Finland
Tooth plaque
6.2
23.8
71
152
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
23.3
22
*
ZXD05
NOMESCO Finland
Urgent procedure
4.3
23.3
114
417
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.3
23.2
68
142
M04AA01
ATC
allopurinol; systemic
11.9
22.5
42
42
ZXE00
NOMESCO Finland
One hour or less
4.0
22.3
145
674
ZX121
NOMESCO Finland
Central venous catheter
88.7
22.1
24
*
A04AA02
ATC
granisetron; systemic, transdermal
88.7
22.1
24
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.4
20.8
91
292
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.9
20.6
77
211
ZXD00
NOMESCO Finland
Emergency procedure
14.5
19.6
33
26
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
19.0
18
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.3
18.2
26
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.5
18.0
74
219
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
17.9
17
*
2301
FHL
Lumbar puncture in anesthesia or operating room
+∞
17.9
17
*
ZX120
NOMESCO Finland
Intravenous
6.8
17.8
47
83
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
193.8
17.8
18
*
A06AD11
ATC
lactulose; oral
5.9
17.6
52
107
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
34.4
17.4
22
7
J05AB01
ATC
aciclovir; systemic
4.2
16.9
75
237
L03AA10
ATC
lenograstim; parenteral
+∞
16.9
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
16.8
69
203
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
15.8
106
466
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
170.7
15.7
16
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
41.0
15.6
19
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
15.1
105
468
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.6
14.8
45
95
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
14.7
14
*
9109
FHL
Other measure in this category
+∞
14.7
14
*
L01BB03
ATC
tioguanine; oral
+∞
14.7
14
*
A01AB09
ATC
miconazole; local oral
5.9
14.6
42
83
ZXA00
NOMESCO Finland
Right side
3.8
14.2
69
233
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
79.8
13.7
15
*
N02AA05
ATC
oxycodone; systemic
7.7
13.7
32
47
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
+∞
13.7
13
*
A02BC01
ATC
omeprazole; systemic
3.5
13.4
74
272
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.7
13.2
34
58
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
13.2
66
227
J01MA12
ATC
levofloxacin; systemic
4.5
13.1
50
134
JN4BD
NOMESCO Finland
Extensive body CT
10.6
13.1
25
26
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.9
13.1
115
586
R4110
NOMESCO Finland
Physiotherapy
3.2
12.7
81
330
L04AA01
ATC
[U] ciclosporin; systemic
21.5
12.7
18
9
C90.0
ICD-10 Finland
Multiple myeloma
+∞
12.6
12
*
2AX04
NOMESCO Finland
NA
136.9
12.6
13
*
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
11.8
43
110
602
Kela drug reimbursment
Children's severe malnutrition
10.1
11.8
23
25
Z2446
NOMESCO Finland
Social worker
3.9
11.6
51
156
L01XE06
ATC
[U] dasatinib; systemic
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
11.5
11
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
11.5
11
*
J02AC03
ATC
voriconazole; systemic
125.8
11.5
12
*
ZX108
NOMESCO Finland
Inhalation
18.9
10.9
16
9
D64.9
ICD-10 Finland
Anaemia, unspecified
5.5
10.8
32
65
L04AA06
ATC
mycophenolic acid; systemic
10.8
10.7
20
20
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
10.6
81
367
WW409
NOMESCO Finland
Other aferesis
114.8
10.5
11
*
B73
ICPC
Leukaemia
+∞
10.5
10
*
150
Kela drug reimbursment
Dasatinib
+∞
10.5
10
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
J02AC04
ATC
posaconazole; systemic
+∞
10.5
10
*
1CX01
NOMESCO Finland
NA
+∞
10.5
10
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.5
10.4
22
28
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
8.5
10.4
22
28
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
10.1
102
543
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.7
10.0
25
41
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
8.4
9.9
21
27
Z2221
NOMESCO Finland
Medical doctor
2.6
9.8
86
420
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
15.9
9.6
15
10
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.0
9.5
26
48
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
31.4
9.5
12
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
31.4
9.5
12
*
L04AD01
ATC
ciclosporin; systemic
9.3
9.5
19
22
2AA01
NOMESCO Finland
NA
+∞
9.4
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.4
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
9.4
9
*
Z3226
NOMESCO Finland
Physiotherapist
2.8
9.4
68
296
A01AB04
ATC
amphotericin B; local oral
8.9
9.3
19
23
FM2CE
NOMESCO Finland
NA
5.2
9.2
28
59
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
38.3
9.1
11
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
93.2
8.5
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.5
8.4
19
27
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
+∞
8.4
8
*
5639
FHL
Other measure in this category
+∞
8.4
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
8.4
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
8.4
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.4
8
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
8.4
8
*
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
17.9
8.2
12
7
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.6
8.1
36
111
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
8.1
55
228
Z31.6
ICD-10 Finland
General counselling and advice on procreation
15.7
7.8
12
8
5604
FHL
Vascular preparation or cannulation in the operating room
46.5
7.8
9
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.5
7.7
36
115
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
26.0
7.6
10
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
82.5
7.5
8
*
ZXA05
NOMESCO Finland
Left side
2.8
7.5
50
206
A07AA02
ATC
nystatin; oral
5.5
7.4
21
41
189
Kela drug reimbursment
Imatinib
+∞
7.3
7
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.6
7.3
20
38
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
20.8
7.2
10
5
ZXA10
NOMESCO Finland
Bilateral
2.7
7.1
50
211
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
7.1
131
880
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.2
7.1
18
31
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
9.7
6.9
13
14
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
6.8
29
86
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
23.3
6.7
9
*
IEP04
NOMESCO Finland
Focused parenting intervention
23.3
6.7
9
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.7
6.6
11
9
A98
ICPC
Health maint/preventive medicine
0.3
6.5
199
2225
M87.3
ICD-10 Finland
Other secondary osteonecrosis
71.7
6.5
7
*
J01MA14
ATC
moxifloxacin; systemic
4.6
6.4
21
49
K02.0
ICD-10 Finland
Caries limited to enamel
2.2
6.4
74
404
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.1
6.4
19
40
B02.9
ICD-10 Finland
Zoster without complication
5.1
6.4
19
40
TGC00
NOMESCO Finland
Bronchial lavation
11.5
6.4
11
10
Z3231
NOMESCO Finland
Registered nurse
2.1
6.3
83
475
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
6.3
17
32
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
6.3
6
*
4CJ01
NOMESCO Finland
NA
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
6.3
6
*
L01AA01
ATC
cyclophosphamide; systemic
+∞
6.3
6
*
324
Kela drug reimbursment
Dasatinib
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.0
6.2
13
17
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
6.2
18
37
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
13.0
6.1
10
8
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
6.1
32
112
WW200
NOMESCO Finland
Immunization
5.8
6.1
16
29
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
10.4
6.1
11
11
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.6
6.0
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
38
15
29.98
55.35
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
36
13
32.47
53.96
1.7
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
47
14.24
52.77
12.8
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
15
27.20
49.35
12.7
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
26
18.86
48.93
4.4
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
39
23
20.10
48.15
7.6
2.4
e9/l
1.2
1.7
0.95
25
16
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
34
15
26.30
47.37
3.4
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
33
15.25
44.64
5.0
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
23
18.88
44.45
6.4
2.3
%
6.6
11.3
1.37
27
18
(1175426) CD3 cells/100 lymphocytes in Blood
37
23
18.88
44.45
6.4
2.3
%
76.9
65.7
1.44
37
23
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
35
14.37
43.09
4.4
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
40
0
+∞
43.04
23.8
0.0
umol/l
0.4
—
—
40
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
19
20.72
42.87
3.3
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
57
10.85
41.74
13.3
1.3
e6/l
29.1
89.7
0.86
45
52
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
57
10.85
41.74
13.3
1.2
e6/l
10.0
6.5
0.15
45
50
(3024932) HLA-DR beta [Type]
28
11
28.73
40.48
1.2
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
28
11
28.73
40.48
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
13
25.28
39.96
9.1
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
34
22
17.88
39.92
8.3
2.0
e6/l
663.8
543.1
0.38
26
17
(3023410) Appearance of Cerebral spinal fluid
38
31
14.41
39.37
15.8
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
65
112
7.62
38.54
2.9
1.8
iu/l
8.4
13.6
1.17
50
95
(3005719) IgG [Mass/volume] in Serum or Plasma
74
147
6.87
38.27
7.3
2.0
g/l
7.7
10.2
6.52
74
139
(3016018) Differential panel - Cerebral spinal fluid
32
20
18.34
38.17
9.5
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
21
17.46
37.24
6.9
2.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
37
12.42
36.75
17.2
9.2
iu/ml
326.2
447.0
—
10
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
64
114
7.32
36.68
3.0
1.9
u/l
6.8
8.0
0.33
46
96
(3023520) Reticulocytes [#/volume] in Blood
65
129
6.57
33.32
11.2
3.1
e9/l
56.7
64.8
1.03
50
99
(44790049)
29
20
16.38
32.78
3.9
1.3
—
—
—
0
0
(44790047)
29
20
16.38
32.78
3.9
1.3
—
—
—
0
0
(44806118)
29
20
16.38
32.78
3.9
1.3
—
—
—
0
0
(44790048)
29
20
16.38
32.78
3.9
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
32
12.24
32.07
3.9
3.8
%
51.5
53.8
0.37
34
32
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
32
12.24
32.07
2.9
3.7
e9/l
3.2
3.8
0.68
34
32
(3000060) B lymphocytes [#/volume] in Blood
27
18
16.80
31.01
7.6
2.2
e6/l
155.8
359.2
0.91
19
12
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
29
12.60
30.88
4.6
1.9
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
27
19
15.91
30.13
7.6
1.8
%
34.6
23.0
2.51
27
19
(3006245) CD3-CD19+ cells/100 cells in Blood
27
22
13.72
27.70
7.6
2.7
%
5.7
15.7
1.53
27
22
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
43
68
7.50
27.11
1.6
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
71
7.18
26.02
1.5
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
68
6.87
23.47
2.0
1.7
u/ml
97.4
105.6
—
8
9
(42870588) Differential panel, method unspecified - Blood
142
668
3.81
22.78
35.2
6.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
27
7
43.21
22.25
1.2
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
143
4.93
21.99
3.2
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
57
146
4.82
21.40
3.3
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
64
182
4.45
21.04
13.9
3.8
umol/l
4.4
7.1
1.02
56
147
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
43
88
5.75
20.84
1.6
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
109
5.27
20.74
11.0
5.0
%
0.6
0.6
0.09
22
30
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
18
12.70
20.74
4.7
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
71
226
4.06
19.97
17.4
2.7
s
31.0
29.9
0.70
71
221
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
85
5.62
19.55
1.5
1.8
u/ml
114.7
171.6
1.33
28
44
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
28
9.42
19.23
4.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
99
5.23
19.15
11.4
5.3
%
0.2
0.0
0.67
19
23
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
47
7.16
18.86
1.7
1.5
nmol/l
0.3
0.4
0.77
23
40
(3025159) Blasts/100 leukocytes in Blood
42
94
5.22
18.36
11.3
5.5
%
0.1
0.0
0.79
17
20
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
64
202
3.97
18.06
4.4
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
170
985
3.57
18.04
34.8
6.0
e9/l
0.5
0.6
3.48
161
852
(3006315) Basophils [#/volume] in Blood
170
988
3.55
17.89
34.8
6.0
e9/l
0.0
0.0
5.43
161
854
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
31
8.50
17.75
1.3
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
172
1010
3.56
17.73
39.9
6.5
e9/l
0.1
0.2
5.59
164
889
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
35
7.87
17.30
2.6
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
35
7.87
17.30
2.9
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
172
1025
3.47
16.98
35.1
6.0
e9/l
1.9
2.1
3.22
165
908
(3002179) Metamyelocytes/100 leukocytes in Blood
41
97
4.90
16.74
10.3
4.8
%
0.6
0.3
0.38
14
17
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
160
4.08
16.53
1.6
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
71
264
3.41
15.45
3.0
3.8
ng/l
623.2
1070.7
1.04
58
218
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
20
9.66
14.85
2.7
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
94
4.62
14.64
4.4
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
110
543
2.91
14.50
16.8
6.0
g/l
35.4
37.2
2.37
104
513
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
82
357
2.98
13.43
11.8
2.0
mg/l
1.8
0.9
1.39
67
258
(3023368) Bacteria identified in Blood by Culture
78
332
3.01
13.29
16.2
3.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
51
171
3.53
12.87
1.7
3.4
%
25.6
23.3
0.42
46
161
(3013650) Neutrophils [#/volume] in Blood by Automated count
168
1081
2.90
12.73
56.8
7.2
e9/l
2.9
3.9
11.77
159
931
(4035726)
26
53
5.39
12.48
1.5
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
17
9.35
12.13
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
12
11.40
12.06
6.6
1.2
pg
33.9
34.2
0.06
13
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
129
744
2.61
11.88
27.7
8.1
mmol/l
1.2
1.2
0.34
111
670
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
5
31.85
11.79
2.9
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
21
8.10
11.56
1.6
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
34
6.33
11.53
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
195
3.21
11.45
2.1
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
678
2.56
11.41
27.1
8.3
mmol/l
1.2
1.2
0.17
115
632
(3017446) Testosterone [Moles/volume] in Serum or Plasma
42
135
3.57
11.23
3.7
2.1
nmol/l
13.0
13.0
0.00
34
118
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
325
2.80
11.22
1.7
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
39
5.81
11.09
2.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
39
5.81
11.09
2.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
37
5.81
10.59
8.7
4.9
u/ml
0.3
0.3
0.18
14
25
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
909
2.49
10.48
18.0
5.2
mmol/l
6.1
6.6
1.96
137
823
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
8
19.90
10.40
6.9
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
8
19.90
10.40
6.9
2.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
15
9.11
10.33
2.8
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
80
390
2.59
10.14
32.0
3.9
%
90.2
91.6
0.23
80
383
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
35
5.81
10.10
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
13
9.67
9.95
19.4
1.9
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
13
5
27.36
9.92
6.8
4.4
e9/l
0.3
0.1
—
13
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
16
8.54
9.83
5.8
3.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
142
909
2.40
9.76
46.6
7.3
e9/l
0.0
0.0
0.78
128
712
(3036481) Cortisol [Moles/volume] in Serum or Plasma
53
215
2.89
9.56
3.5
2.3
nmol/l
339.1
379.6
0.87
53
205
(40760892) CBC W Ordered Manual Differential panel - Blood
81
417
2.43
8.99
10.2
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
15
8.37
8.94
19.8
2.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
8
17.09
8.65
1.9
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
86
462
2.35
8.61
6.0
7.1
inr
1.0
1.2
4.21
24
135
(3044640) Blood type and Crossmatch panel - Blood
85
457
2.34
8.48
14.3
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
75
383
2.40
8.40
11.7
3.2
ph
7.4
7.4
0.28
17
52
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
8
0
+∞
8.38
11.4
0.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
42
4.83
8.28
15.4
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
95
541
2.26
8.23
12.7
2.9
u/l
31.6
30.6
0.22
95
523
(40758558) Short blood count panel - Blood
88
486
2.29
8.20
61.2
5.9
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
5
22.96
8.09
2.7
3.8
%
17.4
8.6
—
11
5
(21494814) CD8 cells/100 lymphocytes in Specimen
11
5
22.96
8.09
2.6
3.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
17
7.38
8.07
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
6
19.13
7.67
5.9
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
363
2.27
7.07
11.3
2.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
8
14.34
6.96
8.0
5.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
515
2.13
6.89
1.8
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
14
7.41
6.75
1.6
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
14
7.41
6.75
2.9
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
568
2.09
6.74
5.3
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
190
2.54
6.45
2.7
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
22
5.69
6.35
1.2
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.27
12.2
0.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
0
+∞
6.27
4.0
0.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
8
12.98
6.14
1.3
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
87
526
2.03
6.12
4.7
3.7
e6/l
41.9
58.9
0.26
74
402
(4062490)
12
23
5.44
6.07
1.8
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
80
477
2.02
5.79
4.9
3.8
e6/l
0.1
0.3
0.68
67
355
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
17
6.10
5.67
1.1
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
21
5.44
5.58
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
78
472
1.97
5.36
5.0
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
75
3.13
5.30
2.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
187
2.37
5.29
1.6
1.5
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(4212803)
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
6
13.73
5.11
12.9
3.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
28
4.46
4.88
1.6
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
216
2.21
4.80
33.7
8.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
36
169
2.33
4.71
3.6
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
35
3.87
4.43
2.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
88
585
1.80
4.38
2.8
1.5
g/l
1.6
2.0
1.11
72
319
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
69
426
1.87
4.35
2.1
3.0
mg/l
2.5
2.7
0.34
61
367
(3018095) Leukocytes [#/volume] in Urine
93
630
1.78
4.34
5.6
4.5
e6/l
58.6
92.6
0.38
79
426
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
6
11.97
4.30
1.4
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
732
1.75
4.22
13.8
3.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
27
117
2.48
4.20
12.2
12.9
mmol/l
0.7
0.5
0.11
18
90
(3004588) Protein electrophoresis panel - Serum or Plasma
16
52
3.23
4.17
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
63
3.01
4.16
2.4
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
48
3.27
4.00
1.5
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
28
129
2.33
3.82
1.9
1.6
mu/l
353.9
318.2
0.22
28
123
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
199
2.08
3.81
42.9
5.5
mmol/l
24.3
23.7
1.07
38
192
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
8
8.97
3.80
1.4
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
79
2.67
3.74
1.5
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
248
1.95
3.60
38.2
5.2
mmol/l
1.9
1.5
0.44
39
187
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
9
7.97
3.58
5.3
6.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
9
7.97
3.58
5.3
6.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
6
10.21
3.51
10.2
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
6
10.21
3.51
10.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
6
10.21
3.51
10.2
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
42
3.22
3.42
1.3
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
14
5.87
3.37
2.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
48
3.04
3.36
1.5
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
148
2.09
3.11
1.8
1.3
u/ml
125.0
334.8
0.66
24
140
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
16
5.13
3.07
1.6
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
182
1563
1.71
3.03
3.9
3.5
mmol/l
2.7
2.8
0.27
177
1461
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.17
2.99
1.2
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
73
506
1.64
2.95
2.5
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
17
4.83
2.94
41.3
2.5
%
10.7
12.2
—
8
17
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
103
2.25
2.91
6.0
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
22
4.21
2.91
1.4
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
77
2.45
2.90
6.3
3.1
mmol/l
1.2
1.2
0.34
18
66
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.80
2.88
4.5
10.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
9
6.80
2.88
2.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
138
1119
1.56
2.81
5.5
4.1
e6/l
83.7
295.8
—
7
13
(3024928) Oxygen saturation in Venous blood
10
31
3.32
2.80
33.4
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
92
2.28
2.76
2.4
1.8
ml/min/173m2
102.8
80.6
—
8
38
(3022313) Gas panel - Capillary blood
31
171
1.94
2.70
6.8
8.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
19
4.32
2.70
1.1
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
296
1.73
2.69
4.3
3.5
e6/l
0.7
0.7
0.09
29
169
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.77
2.61
9.9
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.77
2.61
9.9
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
15
4.77
2.61
9.9
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
11
5.56
2.56
1.2
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
26
3.56
2.51
36.9
2.6
%
68.8
67.5
—
9
26
(3019060) Gas panel - Arterial blood
13
51
2.64
2.49
5.9
12.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
171
1905
0.63
2.45
62.7
11.3
%
37.7
40.5
4.93
138
1599
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
27
3.42
2.42
5.1
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
62
432
1.59
2.41
2.5
2.9
ng/l
18.6
31.9
1.04
40
223
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
17
4.21
2.38
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
1732
0.66
2.37
3.9
3.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
13
4.70
2.28
2.0
3.8
ug/l
73.8
145.5
—
6
13
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
293
1.66
2.28
4.5
3.6
e6/l
2.7
3.1
0.13
26
166
(3016502) Oxygen saturation in Arterial blood
20
101
2.07
2.23
15.6
14.5
%
97.8
96.3
1.62
20
96
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.65
2.22
1.2
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
206
1.70
1.96
7.5
7.7
mmol/l
1.6
0.9
1.10
26
143
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
11
4.62
1.95
2.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
16
3.82
1.94
2.7
2.8
mmol/l
27.0
30.1
—
6
16
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
22
3.25
1.89
1.7
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
564
0.63
1.88
2.1
2.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
94
1.99
1.86
5.2
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
136
0.35
1.82
1.2
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
164
1813
0.69
1.81
69.9
12.6
g/l
336.9
334.6
2.66
164
1798
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
29
2.82
1.81
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
63
468
1.47
1.79
2.9
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
525
0.65
1.61
2.0
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
77
605
1.40
1.61
2.4
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
26
2.74
1.59
1.3
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
12
57
2.16
1.58
1.0
1.5
—
—
—
0
0
(3013512) EKG study
43
304
1.51
1.55
3.1
3.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
168
0.46
1.54
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
15
3.38
1.53
8.4
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
15
3.38
1.53
8.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
15
3.38
1.53
1.4
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
15
3.38
1.53
8.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
21
2.90
1.51
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
59
2.09
1.46
22.6
21.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
208
2180
0.63
1.46
68.1
14.3
g/l
128.9
136.5
7.49
208
2147
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
16
3.17
1.44
8.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
16
3.17
1.44
8.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
16
3.17
1.44
8.4
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
16
3.17
1.44
3.6
2.3
umol/l
10.5
13.6
—
5
16
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.2
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
188
1725
1.43
1.44
62.6
12.3
%
13.7
13.2
4.63
188
1691
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
162
1451
1.37
1.43
23.0
7.5
ml/min/173m2
100.7
96.5
1.38
144
1082
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
67
1.99
1.41
20.5
12.9
%
0.8
0.7
0.57
13
67
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
27
176
1.60
1.39
8.5
8.1
mmol/l
24.9
24.2
1.29
27
171
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
260
1.50
1.38
3.3
3.4
ng/l
135.8
752.9
0.81
25
164
(3035941) MCH [Entitic mass]
208
2177
0.64
1.37
67.6
14.1
pg
30.0
29.7
1.73
208
2146
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
695
1.35
1.36
2.2
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
68
1.96
1.36
20.5
12.8
%
1.6
1.6
0.01
13
68
(3014007) Fractional oxyhemoglobin in Arterial blood
13
68
1.96
1.36
20.5
12.9
%
95.2
94.1
0.55
13
68
(3024731) MCV [Entitic volume]
208
2176
0.64
1.35
67.6
14.1
fl
89.3
88.5
1.37
208
2146
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
204
1908
1.50
1.34
36.0
7.2
u/l
35.3
26.1
4.97
204
1843
(21494755) Public health laboratory ask at order entry panel
15
250
0.57
1.28
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
56
435
1.38
1.23
3.5
3.5
estimate
0.0
0.0
0.50
17
157
(4306422)
6
26
2.34
1.19
1.0
1.2
—
—
—
0
0
(4268621)
5
20
2.53
1.15
2.4
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
194
0.55
1.15
1.5
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
32
2.22
1.09
1.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
34
2.09
1.03
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
84
1.71
1.00
1.1
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
23
2.20
0.98
1.0
1.0
—
—
—
0
0
(4027681)
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
7
36
1.97
0.98
5.6
3.2
mmol/l
1.1
1.3
—
7
36
(3044889) 12 lead EKG panel
110
970
1.25
0.93
3.6
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
99
867
1.24
0.88
3.9
3.5
estimate
0.0
0.0
0.00
18
152
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
665
1.26
0.88
1.9
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
98
858
1.24
0.87
5.6
4.9
estimate
0.0
0.0
0.00
18
160
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
31
1.96
0.85
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
242
1.37
0.84
1.5
1.5
pmol/l
388.7
436.5
0.34
26
216
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
19.3
—
1147.2
—
0
25
(3035350) Ketones [Presence] in Urine by Test strip
97
856
1.23
0.79
3.6
3.4
estimate
0.0
0.0
0.00
16
157
(3000475) Leukocytes [#/volume] in Synovial fluid
0
26
0.00
0.79
0.0
1.5
—
21053.8
—
0
20
(3002256) Pathology report gross observation
19
134
1.45
0.74
1.6
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
60
506
1.25
0.74
2.0
1.7
pmol/l
104.0
96.6
0.43
34
265
(3016879) Cocaine [Presence] in Urine
15
215
0.68
0.71
1.3
1.9
—
—
—
0
0
(3020891) Body temperature
7
41
1.73
0.70
5.9
4.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
119
0.58
0.69
1.9
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
93
0.53
0.68
2.8
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
50
417
1.25
0.68
3.2
3.0
kg/l
1.0
1.0
—
7
61
(4010399)
15
103
1.49
0.66
1.1
1.4
—
—
—
0
0
(4094501)
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
105
0.56
0.63
2.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
449
1.23
0.63
2.2
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
49
1.65
0.62
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
73
640
1.20
0.62
3.7
3.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
242
0.72
0.61
1.7
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
21
158
1.36
0.59
1.1
1.2
—
16.2
—
0
5
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.5
—
4.6
—
0
16
(3021901) Oxygen saturation in Capillary blood
6
35
1.73
0.58
2.8
2.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
6
35
1.73
0.58
7.7
17.8
mmol/l
1.5
1.2
—
6
28
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
124
1.40
0.57
1.1
1.4
miu/ml
361.6
278.6
—
5
67
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
272
0.75
0.57
1.1
1.3
u/ml
1.1
8.4
—
8
103
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
417
1.22
0.56
3.9
3.4
—
—
—
0
0
(3000492) Spirometry study
13
181
0.70
0.55
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
202
0.73
0.53
1.5
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
156
0.69
0.51
1.7
2.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
156
0.69
0.51
1.8
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
127
1.36
0.51
12.9
5.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
65
1.40
0.51
2.2
3.4
—
—
—
0
0
(3019225) pH of Specimen
14
102
1.40
0.48
17.9
4.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
187
0.73
0.47
4.2
3.3
%
19.3
24.7
—
5
76
(3037467) Urinalysis macro (dipstick) panel - Urine
129
1207
1.15
0.47
5.7
4.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
48
1.47
0.47
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
117
0.67
0.47
1.9
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
104
1.37
0.44
1.6
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
57
1.42
0.42
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
32
1.57
0.42
1.2
3.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
158
1508
1.14
0.41
4.6
3.1
mmol/l
5.6
5.7
0.17
153
1378
(3044941) Cell count panel - Synovial fluid
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
36
1.40
0.38
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
37
1.36
0.37
2.2
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
51
568
0.87
0.35
3.0
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
46
1.31
0.33
1.5
1.9
nmol/l
1.5
0.6
—
6
39
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
46
1.31
0.33
14.3
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
137
1.26
0.33
1.1
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
194
1888
1.15
0.33
46.6
9.9
mg/l
18.3
21.2
0.81
170
1358
(3028300) Cannabinoids [Presence] in Urine
19
229
0.81
0.32
1.4
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
97
0.71
0.31
1.1
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
227
0.82
0.30
1.4
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
167
1.22
0.29
2.3
2.4
u/l
24779.8
4662.4
—
6
67
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
57
1.23
0.29
1.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
57
1.23
0.29
1.1
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
226
0.83
0.29
1.4
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
226
0.83
0.29
1.4
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
149
1.23
0.28
3.0
3.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
172
0.80
0.28
1.4
2.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
117
0.76
0.28
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
117
0.76
0.28
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
117
0.76
0.28
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
117
0.76
0.28
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
181
0.82
0.26
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
53
486
1.12
0.25
3.4
3.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.4
—
13525.6
—
0
5
(4146454)
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
9.8
—
11.1
—
0
12
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
4.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
43
1.17
0.21
1.0
1.1
—
12.6
—
0
8
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
13
0.00
0.21
0.0
3.4
—
4.0
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
111
0.80
0.20
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
2.0
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
51
1.18
0.19
5.2
3.5
mmol/l
23.6
22.9
—
6
44
(40768443) Skin Pathology biopsy report
6
53
1.14
0.19
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
330
0.90
0.18
2.0
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(3015736) pH of Urine
73
694
1.07
0.17
3.7
3.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
68
0.73
0.17
2.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
69
0.72
0.17
2.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
70
0.71
0.17
2.4
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
129
0.85
0.15
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
326
0.91
0.15
3.7
4.3
mg/mmol
6.3
13.7
1.13
24
222
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
83
1.09
0.15
1.1
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
195
1977
0.92
0.14
24.0
8.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
98
0.81
0.14
1.6
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
279
1.09
0.12
1.1
1.3
iu/ml
10.0
31.8
—
6
84
(40768797) Stomach Pathology biopsy report
20
183
1.10
0.10
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
96
1.15
0.10
4.6
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.07
0.09
5.0
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
54
1.11
0.09
1.3
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
57
1.05
0.08
1.0
1.9
u/l
49.3
42.0
—
6
52
(3023511) Choriogonadotropin [Units/volume] in Urine
10
113
0.88
0.08
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
58
1.04
0.08
1.0
1.4
—
—
—
0
0
(4034850)
5
63
0.79
0.08
9.2
9.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
317
0.94
0.08
2.9
3.5
mg/l
1696.8
95.4
0.46
25
220
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
95
0.84
0.07
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
95
0.84
0.07
1.5
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
187
1.08
0.06
1.2
1.2
iu/ml
182.8
137.3
0.28
12
71
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
91
1.10
0.04
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
319
1.04
0.04
1.8
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
46
449
1.03
0.03
1.6
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
128
0.93
0.02
2.6
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
66
651
1.02
0.02
1.4
1.6
u/ml
0.7
2.4
2.05
19
140
(3028707) Methadone [Presence] in Urine by Screen method
10
107
0.93
0.02
1.5
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
266
0.97
0.00
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
106
1.04
0.00
1.6
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
266
1.02
0.00
1.6
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
36
358
1.01
0.00
1.9
3.0
ug/g
83.3
83.9
0.01
28
279
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
17.7
—
0
6
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.2
—
516.0
—
0
5
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
12.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
69
0.87
0.00
1.0
1.1
—
14.9
—
0
8
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
96
0.94
0.00
2.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
87.5
—
0
6
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
2187.5
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
3.4
—
1.2
—
0
8
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
66.8
—
0
6
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
4.4
—
1.3
—
0
8
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
76
0.92
0.00
1.9
2.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HLP_C3_ALL – Acute lymphocytic leukaemia, helper endpoint

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).